Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,301 | 813 | 49,945 | 11,202 | 6,844 |
| Marketable Securities | 20,195 | 26,507 | 299 | 72,928 | 30,034 |
| Other current assets | 198 | 5,108 | 0 | 0 | 0 |
| TOTAL | $25,993 | $33,764 | $52,330 | $86,442 | $38,121 |
| Non-Current Assets | |||||
| PPE Net | 625 | 1,539 | 9,875 | 2,530 | 1,481 |
| Other Non-Current Assets | 1,069 | 1,528 | 5,437 | 6,174 | 756 |
| TOTAL | $1,694 | $3,067 | $15,312 | $8,704 | $2,237 |
| Total Assets | $27,687 | $36,831 | $67,642 | $95,146 | $40,358 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 811 | 827 | 1,948 | 878 | 463 |
| Accrued Expenses | 2,846 | 4,001 | 4,659 | 3,840 | 2,738 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,171 |
| TOTAL | $3,799 | $6,061 | $6,607 | $4,718 | $4,372 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 299 | 686 | 4,194 | 5,389 | 499 |
| TOTAL | $299 | $686 | $4,194 | $5,389 | $499 |
| Total Liabilities | $4,098 | $6,747 | $10,801 | $10,107 | $4,871 |
| Shareholders' Equity | |||||
| Common Shares | 2,685 | 2,137 | 2,117 | 2,107 | 1,646 |
| Retained earnings | -127,107 | -112,093 | -83,025 | -51,965 | -37,497 |
| Other shareholders' equity | 1,101 | 1,101 | 1,101 | 1,101 | 977 |
| TOTAL | $23,589 | $30,084 | $56,841 | $85,039 | $35,487 |
| Total Liabilities And Equity | $27,687 | $36,831 | $67,642 | $95,146 | $40,358 |